STOCK TITAN

Clearmind Medicine: Abbe reports 9.99% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Clearmind Medicine Inc. (CMND) is the issuer named in an amended beneficial-ownership report by Iroquois Capital Management, LLC, its president Richard Abbe, and Kimberly Page, who are both directors of Iroquois Master Fund. As of September 30, 2026, the reporting-person cover pages list beneficial ownership of 335,000 common shares for Iroquois Capital Management and Kimberly Page, and 650,000 for Abbe; these amounts include shares issuable upon exercise of warrants. Iroquois Master Fund held no common shares and warrants to purchase 335,000 shares, while ICIG held no common shares and warrants to purchase 315,000 shares. The warrant terms restrict exercise if post-exercise beneficial ownership would exceed 9.99%; certain warrants have a 4.99% blocker. The reported 9.99% ownership percentages are based on 2,145,211 common shares outstanding as of July 31, 2026.

Beneficial ownership — Iroquois Capital Management, LLC 335,000 shares As of September 30, 2026; includes shares issuable upon warrant exercise.
Beneficial ownership — Richard Abbe 650,000 shares As of September 30, 2026; includes shares issuable upon warrant exercise.
Beneficial ownership — Kimberly Page 335,000 shares As of September 30, 2026; includes shares issuable upon warrant exercise.
Iroquois Master Fund reported warrants 335,000 shares Warrants to purchase common shares as of September 30, 2026.
ICIG reported warrants 315,000 shares Warrants to purchase common shares as of September 30, 2026.
Common shares outstanding 2,145,211 shares As of July 31, 2026; used as the basis for reported ownership percentages.
Reported ownership percentage 9.99% Reported for each person; gives effect to applicable blockers.
Certain warrant exercise blocker 4.99% Certain reported warrants are subject to this blocker.
beneficial ownership regulatory
"may be deemed to be the beneficial owner"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Reported Warrants technical
"the Company's reported warrants (the "Reported Warrants")"
Blockers technical
"(collectively, the "Blockers")"
shared voting power technical
"Shared Voting Power 335,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power technical
"Shared Dispositive Power 335,000.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Clearmind (CMND) warrants did the Iroquois entities report?

Iroquois Master Fund held warrants to purchase 335,000 Clearmind common shares, and ICIG held warrants to purchase 315,000 shares, as of September 30, 2026. Both entities held zero common shares.

Who has investment authority over the Clearmind (CMND) warrants?

Richard Abbe and Kimberly Page share authority and responsibility for investments made for Iroquois Master Fund. Abbe has sole authority and responsibility for investments made for ICIG. Iroquois Capital Management is the investment advisor to Iroquois Master Fund.

What limits apply to exercising Clearmind (CMND) warrants?

The reported warrants cannot be exercised to the extent that exercise would leave the reporting persons beneficially owning more than 9.99% of outstanding common shares. Certain warrants are subject to a 4.99% blocker instead.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





185053600

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 335,000 Common Shares issuable upon exercise of Warrants (See Item 4). As more fully described in Item 4, certain Warrants are subject to a 9.99% blocker (other than certain Warrants which are subject to a 4.99% blocker), and the percentage set forth in row (11) gives effect to such blockers. The shares reported in rows (6), (8) and (9) show the number of Common Shares issuable upon exercise of such reported securities, giving effect to the 9.99% blocker.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 650,000 Common Shares issuable upon exercise of Warrants (See Item 4). As more fully described in Item 4, certain Warrants are subject to a 9.99% blocker (other than certain Warrants which are subject to a 4.99% blocker), and the percentage set forth in row (11) gives effect to such blockers. The shares reported in rows (5), (6), (7), (8) and (9) show the number of Common Shares issuable upon exercise of such reported securities, without giving effect to the 9.99% blocker.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 335,000 Common Shares issuable upon exercise of Warrants (See Item 4. As more fully described in Item 4, certain Warrants are subject to a 9.99% blocker (other than certain Warrants which are subject to a 4.99% blocker), and the percentage set forth in row (11) gives effect to such blockers. The shares reported in rows (6), (8) and (9) show the number of Common Shares issuable upon exercise of such reported securities, without giving effect to the 9.99% blocker.


SCHEDULE 13G



Iroquois Capital Management, LLC
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe, President
Date:11/13/2026
Richard Abbe
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe
Date:11/13/2026
Kimberly Page
Signature:/s/ Kimberly Page
Name/Title:Kimberly Page
Date:11/13/2026

Keep reading